Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390956
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-04-17
Brief Title:
Pirtobrutinib in Combination With Rituximab in Newly Diagnosed Marginal Zone Lymphoma RPirto in Newly Diagnosed MZL
Sponsor:
Organization:
Ohio State University Comprehensive Cancer Center